Profilo
Wendy Chapman, who previously worked at PAREXEL International Corp., YM BioSciences, Inc., and Viventia Biotech, Inc., held senior positions in clinical operations and portfolio direction.
She was also the Chief Operating Officer and Vice President of Clinical Operations at Viventia Biotech, Inc. Most recently, she served as the Senior Vice President of Clinical Operations at Sierra Oncology, Inc. from 2014 to 2022.
Precedenti posizioni note di Wendy Chapman
| Società | Posizione | Fine |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Corporate Officer/Principal | 01/07/2022 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Direttore operativo | - |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Health Technology |
Sierra Oncology, Inc.
Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
















